Lizorp 250 mg and 500 mg TABLETS
PDF Leaflet Revision Date: 05 February 2021
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of mild to moderately severe infections caused by susceptible bacteria.
Dosage (summary)
Adults: 500 mg every 12-24 hours for 10 days depending on infection type.
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Safety in pregnancy and lactation not established.
Key Drug Interactions
- Increases risk of bleeding with warfarin
- Nephrotoxicity with aminoglycosides
Contraindications
- Allergy to cephalosporins
- Children under 1 year
- Pregnancy and lactation
Common side effects
- Nausea
- Vomiting
- Diarrhoea
- Eosinophilia
- Dizziness
Counselling Points
- Monitor for allergic reactions
- Report severe diarrhea
- Evaluate renal function during therapy
Serious warnings
- Serious hypersensitivity reactions
- Pseudomembranous colitis risk
Important Disclaimer
The Lizorp 250 mg and 500 mg TABLETS professional information leaflet below is the property of Aurogen South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
